Medacta Group SA
SIX:MOVE
EV/S
Enterprise Value to Sales
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
Market Cap | EV/S | ||||
---|---|---|---|---|---|
CH |
Medacta Group SA
SIX:MOVE
|
2.4B CHF | 5.1 | ||
US |
Abbott Laboratories
NYSE:ABT
|
180.7B USD | 4.6 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
143.6B USD | 18.9 | ||
US |
Stryker Corp
NYSE:SYK
|
127.8B USD | 6.5 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
111.4B USD | 8.1 | ||
IE |
Medtronic PLC
NYSE:MDT
|
109.4B USD | 3.9 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
66.5B USD | 4 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
59.8B EUR | 3.3 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
53B USD | 8.4 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
365.4B CNY | 9.7 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
50.5B USD | 13.2 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.